Cancer Cause and Prevention Research in Minnesota
Cancer Cause and Prevention Research (93.393) awarded $138 million to recipients in Minnesota in 81 grants from fiscal 2021 to 2025, 3.8% of the program's national total. Mayo Clinic Jacksonville (a Nonprofit Corporation) received the most, $63.9 million.
- Awarded in Minnesota$138 million
- Awards81
- Share of the program3.8%
- Rank among states8th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 36 | $23.2 million |
| FY 2022 | 47 | $30.1 million |
| FY 2023 | 48 | $30.6 million |
| FY 2024 | 48 | $26.9 million |
| FY 2025 | 43 | $27.4 million |
Recipients in Minnesota
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Mayo Clinic Jacksonville (a Nonprofit Corporation) | Nonprofits | 37 | $63.9 million |
| Regents of the University of Minnesota | Colleges and universities | 39 | $60.9 million |
| Hennepin Healthcare Research Institute | Nonprofits | 1 | $7.5 million |
| Healthpartners Institute | Nonprofits | 2 | $3.7 million |
| Xanthoshealth, Inc. | Small businesses | 1 | $1.9 million |
| Daynamica Inc | Small businesses | 1 | $399,865 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Minnesota?
$138 million from fiscal 2021 to 2025, across 81 awards. Minnesota ranks 8th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Minnesota?
The largest recipient is Mayo Clinic Jacksonville (a Nonprofit Corporation), with $63.9 million in 37 awards. Next are Regents of the University of Minnesota and Hennepin Healthcare Research Institute.
Can organizations in Minnesota apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Minnesota
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Temporary Assistance for Needy Families
- Federal Transit Capital Investment Grants
- Special Education Grants to States
- Child Care and Development Block Grant
- Federal Transit Formula Grants
- Affordable Rural Cooperative